Stock & Company Details
GRI Bio Inc $GRI
Price:
N/A
N/A
2.2M
$3.6M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.02
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Investment Trust/Mutual Fund
GRI technical indicators
Latest GRI Bio Inc (GRI) indicator readings as of 2026-10-29.
GRI's 14-day RSI is 45.5, in neutral territory. At $1.57 it is trading 23.5% below its 200-day moving average of $2.05, and below its 50-day average of $1.82. Price sits in the middle of its Bollinger Bands ($1.23 to $1.96). ADX reads 17.7, indicating a range-bound market rather than a trend.
Overview
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis.
Finance Bot
Ask your questions
Start by typing a question below.
